ADVERTISEMENT
ADVERTISEMENT

Notebook

The American Medical Association (AMA), not to be outdone by the recent controversies surrounding sheep cloning, wrestled with a few ethical issues of its own earlier this month in Philadelphia. At a conference entitled "Ethics and American Medicine: History, Change, and Challenge," speakers tackled subjects such as end-of-life care and the problems of managed care and health-care rationing. The meeting’s concluding session, a roundtable discussion on medicine’s future ethical chall

The Scientist Staff

The American Medical Association (AMA), not to be outdone by the recent controversies surrounding sheep cloning, wrestled with a few ethical issues of its own earlier this month in Philadelphia. At a conference entitled "Ethics and American Medicine: History, Change, and Challenge," speakers tackled subjects such as end-of-life care and the problems of managed care and health-care rationing. The meeting’s concluding session, a roundtable discussion on medicine’s future ethical challenges, focused on the prospect of the genetics revolution reaching the bedside. Americans apparently are giving it some thought. While a recent AMA survey showed that three-fourths of Americans say they would be tested for specific genes, more than eight out of 10 are concerned about the privacy of genetic information. And well they should be, said Francis Collins, director of the National Human Genome Research Institute. As the Human Genome Project leaps toward completion by approximately 2005, society faces questions...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
ADVERTISEMENT